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Abstract
Background: The majority of births in Mexico take place in a health facility and are attended by a skilled birth
attendant, yet maternal mortality has not declined to anticipated levels. Coverage estimates of skilled attendance
and other maternal and newborn interventions often rely on women’s self-report through a population-based
survey, the accuracy of which is not well established.
Methods: We used a facility-based design to validate women’s report of skilled birth attendance, as well as other
key elements of maternal, newborn intrapartum, and immediate postnatal care. Women’s reports of labor and
delivery care were collected by exit interview prior to hospital discharge and were compared against direct
observation by a trained third party in a Mexican public hospital (n = 597). For each indicator, validity was assessed
at the individual level using the area under the receiver operating curve (AUC) and at the population level using
the inflation factor (IF).
Results: Five of 47 indicators met both validation criteria (AUC > 0.60 and 0.75 < IF < 1.25): urine sample screen,
injection or IV medication received during labor, before the birth of the baby (i.e., uterotonic for either induction
or augmentation of labor), episiotomy, excessive bleeding, and receipt of blood products. An additional 9 indicators
met criteria for the AUC and 18 met criteria for the IF. A skilled attendant indicator had high sensitivity (90.1 %:
95 % CI: 87.1–92.5 %), low specificity (14.0 %: 95 % CI: 5.8–26.7 %) and was suitable for population-level estimation
only.
Conclusion: Women are able to give valid reports on some aspects of the content of care, although questions
regarding the indication for interventions are less likely to be known. Questions that include technical terms or
refer to specific time periods tended to have lower response levels. A key aspect of efforts to improve maternal
and newborn health requires valid measurement of women’s access to maternal and newborn health interventions
and the quality of such services. Additional work on improving measurement of population coverage indicators is
warranted.
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Background
The maternal mortality ratio in Mexico has declined by
less than 7 % in the past two decades [1]. As part of its ef-
forts to improve maternal health, the Mexican govern-
ment has emphasized increasing access to skilled obstetric
care as a central focus of the national health plan [2, 3].
To scale-up access, government-led initiatives have sought
to promote contact with the health system and skilled
birth attendance, establishing policies such as universal
health coverage for pregnant women and no-cost emer-
gency obstetric services [3].
To track such efforts, the Mexican government has
emphasized monitoring women’s contact with the health
system [4]. Indicators routinely collected as proxy mea-
sures for skilled obstetric care include the proportion of
births delivered in health facilities and the proportion of
births attended by a skilled birth attendant. In the
absence of health monitoring systems that can provide
accurate data on population coverage, these indicators
often rely on women’s self-reports collected in house-
hold surveys such as the National Health and Nutrition
Survey (Encuesta Nacional de Salud y Nutrición) in
Mexico or international programs including the Demo-
graphic and Health Surveys (DHS) and Multiple Indica-
tor Cluster Survey (MICS). However, the accuracy of
women’s reports on these indicators is not well under-
stood [5].
Insufficient progress in improving maternal health in
Mexico and elsewhere has called into question reliance
on indicators of health system contacts, rather than the
content and quality of care. For example, researchers
have noted that while physician-attended births were
reported to be near universal in Mexico in 2012 (96 %),
maternal deaths have not declined to the anticipated
level [6–9].
A small, but emerging evidence base has sought to val-
idate which aspects of maternal and newborn care women
are able to report with accuracy. Validation research to
date has largely taken place in settings where maternal
mortality rates are low and often relies on hospital
records, which often are subject to incomplete and
inaccurate reporting as the reference standard. Although
three rigorous studies were recently published in this area,
to our knowledge, one of the most widely used indicators
of health service contact – skilled attendance at birth– re-
mains to be empirically validated [10–12]. In addition,
apart from research by Tuncalp and colleagues which
focused on validating women’s reports of cesarean section
in the Dominican Republic [11], we know of little research
to validate indicators of the quality and content of mater-
nal and newborn health care in the Latin America and
Caribbean region.
This study responds to the need for enhanced data
related to the measurement of maternal and newborn
health intervention coverage. We assessed the validity of
a set of intrapartum and immediate postnatal indicators
among women who delivered in a large Mexican public
hospital. Our goal is to inform which aspects of intrapar-
tum and immediate postnatal care women are able to
report with accuracy and have the potential to be
included in routine population-based surveys to monitor
the coverage of lifesaving maternal and newborn health
interventions.
As part of this work, a parallel study validated a set of
quality of care indicators in Kenya [13]. Given variation
in the status of maternal health and the organization of




Data for the validation analysis were drawn from
women’s reports on the maternal and newborn health
services they received during labor and delivery gath-
ered by exit interviews prior to their discharge from
the hospital. Women’s reports were compared against
observations by a trained third party using a structured
checklist. Direct observation was chosen as the refer-
ence standard as it was considered to yield the most
accurate reflection of all facets of the care-giving
process. In the event that clarification was needed
(e.g., in a few instances the newborn and mother were
taken into separate rooms and the observer remained
with the mother) observations were supplemented by
checking medical records or by consulting providers.
Study setting and population
The study took place in a large public hospital in Mexico
City where approximately 4,000 deliveries (54 % vaginal)
take place annually. Hospital services include compre-
hensive obstetric care to women with normal pregnan-
cies who are self-referred for admission, in combination
with women with high-risk pregnancies who are referred
from other public primary or secondary health care
institutions. The population served by the study hospital
tends to have a lower-than-average socioeconomic status
and characteristically lacks health insurance. Patients
may travel large distances to arrive at the study hospital
with a large proportion from the neighboring State of
Mexico (37 %) and 5 % from the rest of the country.
All pregnant women aged 15−49 who were admitted for
delivery at the study hospital and were able to provide
consent were eligible for participation. Women were
excluded if they were unable to provide consent, if they
presented with a complication, or if their stage of labor
was considered too advanced by medical personnel. Study
observation was discontinued if a cesarean section was
indicated at any point.
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Ethical approval and consent
Written informed consent was obtained from all partici-
pants prior to observation. For women under the age of
18, written consent was also obtained from their spouse/
common law partner or parent (as responsible parties)
in accordance with local ethical guidelines [14]. Provider
consent was obtained to observe health care workers in
the labor and delivery ward. A list of providers who gave
their consent was provided to observers before they
commenced observation. Very few providers refused
participation.
The study protocol was approved by the Population
Council’s Institutional Review Board and the Ethics and
Research Committee of the participating hospital prior
to participant enrollment.
Data collection
Data collection took place between November 2013
and April 2014 and occurred over a 24-h period,
using three daily observation shifts. Observations
included all interactions between women and pro-
vider (s) upon admission to the labor ward until one
hour following delivery. Client exit-interview ques-
tionnaires reflected the same elements of care and
patient-provider interactions as the observation
checklist (Additional files 1, 2, 3 and 4). Observers
were general medical practitioners or nurses with
sufficient clinical training to accurately record deliv-
ery room practices. Interviewers were social workers
and psychologists with prior research experience. To
minimize the potential for bias, study interviewers
and observers were not the same individuals and all
data collectors were external to the study facility. We
recruited only female interviewers to facilitate rap-
port with participating women and interviews were
conducted in Spanish. Data collectors received inten-
sive training on the study protocol, including detailed
explanation of each aspect of the client questionnaire
and observation checklist to ensure full understand-
ing, how to record responses, and the procedures for
ethical research.
Indicator selection
Indicators selected for validation were identified through
a landscaping scan of published and grey literature con-
ducted between April and July 2012, a detailed descrip-
tion of which is published elsewhere [13]. Inclusion
criteria for indicator selection were: reflection of the
content or quality of maternal and newborn health
services relating to the early labor and immediate post-
natal period (up to one hour following delivery) [15],
current or proposed use in household survey programs
(e.g., DHS or MICS) or the ability to reflect critical ele-
ments of care and be recalled by women. A total of 82
indicators were selected for validity testing (Additional
file 5: Table S1).
Interview questionnaires were translated into Spanish
and underwent minor modifications to improve partici-
pant understanding.
Sample size
The target sample size for this study was 600 women.
Since no information on the coverage of maternal and
newborn interventions in the facility was available, we
assumed 50 % prevalence for all indicators, with 60 %
sensitivity ± 6 % precision, 70 % specificity ± 6 % preci-
sion, and with α = 0.05 assuming normal approximation
to the binomial distribution. Using these assumptions, a
target sample size of 500 was calculated. To allow for
non-response, the sample size was increased to approxi-
mately 600 women.
Data analysis
Analyses were performed using Stata Version 12
(StataCorp, College Station, TX). We assessed two
aspects of indicator validity, accuracy at the individ-
ual level and population level. To measure individual
level reporting accuracy, we compared women and
observer responses to a single or combination of
questions computed for each indicator by construct-
ing two-by-two tables. Missing and “Don’t Know”
responses were excluded from the analysis. Where
there was sufficient sample size (i.e., at least five
counts per cell), we plotted the receiver-operating
curve for each indicator. Receiver operating curve
(ROC) analysis provides a global statistic of indicator
accuracy by plotting the tradeoff between indicator
sensitivity (i.e., the true positive rate), against its
false positive rate (or 1 – specificity) [16]. To
summarize the average accuracy of each indicator,
we calculated the area under the receiver-operating
curve (AUC). AUC scores range from 0 to 1, with
an AUC of 0.5 representing a random guess and an
AUC of 1 representing perfect diagnostic accuracy.
For the purposes of this study we used an AUC of
0.6 or greater as an a priori benchmark of validity
[12]. We present estimates of sensitivity, specificity
and the AUC with accompanying 95 % confidence
intervals (CIs) assuming a binomial distribution.
To estimate the prevalence that would be obtained for
each indicator if assessed in a population-based survey
(Pr), we applied the sensitivity (SE) and specificity (SP)
calculated for each indicator to its true prevalence (P)
(i.e., observer report) using the following equation: Pr =
P x (SE + SP-1) + (1-SP) [17]. We then calculated the
inflation factor (IF), or the ratio of the survey-based
prevalence to the true prevalence, to estimate the degree
to which each indicator would be over or under-
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estimated if assessed at the population level. A priori
validation criteria for the IF was set at 0.75 < IF < 1.25
[12].
We defined overall acceptable indicator performance
in terms of meeting both the individual (AUC) and
population-level (IF) criteria (0.60 < AUC and 0.75 <
IF < 1.25). However, we note that indicator validity
criteria should be weighed according to the indicator’s
intended use. For example, an indicator with low
accuracy at the individual-level may produce an
acceptable estimate of population-level coverage if the
false positive reports and false negative reports yield a
ratio of approximately one. Given this, we refer
readers to the full validation results.
Results
Sample descriptive characteristics
In total, 779 women admitted for labor gave consent to
participate. Due to hospital policies that allowed complete
observation of women who underwent vaginal deliveries
only, data collection for women who delivered by cesarean
section was discontinued at the time of indication. Six
hundred and sixteen women who consented to participate
delivered by vaginal birth (Fig. 1). Of these women, 597
(97 %) were observed throughout labor and delivery and
completed an exit interview before hospital discharge. The
age, marital status, parity and education for women are
presented in Table 1.
Validation results
The full list of indicators selected for validity testing as
well as the prevalence of each indicator as reported by
women and observers is presented in Additional file 5:
Table S1. For all survey questions, women could respond
“I Don’t Know”. Across indicators, “Don’t Know”
responses were generally minimal. Greater than 5 % of
women responded “Don’t Know” to 9 indicators
(Table 2).
The highest percentage of women responded “Don’t
Know” to questions regarding administration of
oxytocin (i.e., uterotonic for the prevention of post-
partum hemorrhage) at any time or before the deliv-
ery of the placenta (53 % and 38 %, respectively). An
alternate proxy indicator regarding receipt of a utero-
tonic for prevention of postpartum hemorrhage –
whether, immediately after delivery, “anyone [gave]
medication intravenously through a tube in your arm”
– also exceeded 5 % (8 %) “Don’t Know” responses.
High percentages of “Don’t Know” responses were
also recorded for several immediate postnatal inter-
ventions for the mother and newborn. In addition,
Fig. 1 Participant response rates. Enrollment and response rates
reflect women who delivered by vaginal birth only
Table 1 Percent distribution of women by background
characteristics
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nearly one-quarter of women did not know whether
they received an HIV test. Anecdotal evidence from
data collectors indicated that many women did not
know what HIV was, or confused it with human pap-
illomavirus (HPV).
There was adequate cell size to validate 47 indica-
tors: five of which met both validation criteria
(Table 3). These were: urine sample screen (i.e., check
for preeclampsia), injection or IV medication received
during labor and before the birth of the baby (i.e.,
proxy for uterotonic for either induction or augmen-
tation of labor), episiotomy, hemorrhage, and receipt
of blood products. An additional 27 indicators met
either the criteria for individual-level classification
(AUC) (9 indicators) or population-level coverage (IF)
(18 indicators). We discuss the results below in rela-
tion to: (1) contact with the health system, (2) con-
tent and quality of maternal and immediate newborn
health care, and (3) maternal health outcomes.
Contact with the health system
Indicators of contact with the health system were: the
type of provider involved in labor and delivery care and
the type of facility where the delivery took place.
Skilled birth attendance
To assess skilled birth attendance, women were
asked, “Who was the main provider assisting you
during delivery?” Cross-tabulation results of observer
and women’s reports of provider type showed that
most women reported attendance by a doctor (either
a general provider or a doctor with specialization in
obstetrics and gynecology (ob-gyn)), while most
observers reported attendance by a medical resident
(Table 4). In Mexico, there is little distinction be-
tween the type of care doctors and medical residents
are legislated to provide. However, while doctors and
medical residents are considered ‘skilled’, medical
interns are not. To assess the accuracy of women’s
reports of a ‘skilled’ attendant, we assessed a com-
bined doctor and medical resident indicator. The true
prevalence of skilled attendance during delivery (i.e.,
the main provider who ‘caught’ the baby was a
doctor or medical resident) was 91 % and the re-
ported prevalence was 90 %. This indicator had high
sensitivity (90 %, 95 % CI: 87–93), low specificity
(14 %, 95 % CI: 6–27 %) and met the IF criterion
only (AUC: 0.52, 95 % CI: 0.48–0.56; IF 0.98).
Institutional delivery
Although this study was not designed to assess recall of
the type of institution for delivery given that it took place
in one facility only, for exploratory purposes women were
asked to identify where they gave birth and whether it was
a public or private sector facility. Replicating the method-
ology of the DHS and MICS surveys, women were also
asked to specify the facility type (e.g., hospital, health
clinic/center, health post, or other location). If women
were unable to provide this information, they were asked
to name the place.
Among women who responded to the question on
whether the facility was classified as public or private
sector and then specified its type, 85 % were correct.
Among women who responded to the open-ended com-
ponent of the question only: 83 % correctly named the
facility, 9 % identified the facility as a hospital but did
not identify the sector, and four percent identified both
Table 2 Percentage of women who responded “Don’t Know” to survey questions
Client question Na % “Don’t Know”
Immediately after the delivery of your baby, did anyone give you a medication or injection
called oxytocin to help your uterus contract/become firm?
592 38.3
Did anyone give you medication or an injection called ‘oxytocin’ before you delivered the
placenta?
414 52.9
While you were at the health facility for the birth of your baby, did you receive a HIV test? 596 23.7
Did you or anyone else give anything to the baby to eat or drink within the first hour after
delivery?
593 21.4
Did the health provider(s) wash their hands with soap and water or use antiseptic before
examining you?
592 19.4
Just after the delivery of your baby, in the first few minutes after the delivery of your baby,
did anyone give you medication intravenously (through a through a tube in your arm)?
547 7.7
Was your baby dried off with a towel immediately, within a few minutes after his/her birth ? 593 6.6
About how long after birth was your baby bathed for the first time? 573 19.7
In your first physical examination/check after delivery, did a health provider check your belly
to see whether your womb was becoming firm after the birth of your baby?
597 5.9
aSample sizes vary by question due to the number of women who responded to each question. Note: In “Don’t Know” responses were excluded in the validation
analysis. High ‘Don’t Know’ indicators were considered to be those questions to which greater than 5 % of women responded “I Don’t Know”
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Indicators of Health Service Contacts
Main provider labor- doctor
or medical resident
580 96.2 82.3 (78.8-85.3) 27.3 (10.7-50.2) 81.9 0.55 (0.51-0.59) 0.85 IF
Main provider delivery– doctor
or medical resident
563 91.1 90.1 (87.1-92.5) 14.0 (5.8-26.7) 89.7 0.52 (0.48-0.56) 0.98 IF
Indicators of Content of Care
Takes urine sample 572 25.2 50.0 (0.63-0.71) 84.4 (80.6-87.7) 24.3 0.67 (0.63-0.71) 0.97 Both
Injection or IVg medication
received at some time during labor,
before birth of baby (general)
571 76.0 70.1 (65.5-74.3) 56.9 (48.2-65.4) 63.6 0.63 (0.59-0.68) 0.84 Both
Episiotomy performed 580 67.8 97.7 (95.7-98.9) 63.1 (55.8-70.0) 78.1 0.80 (0.77-0.84) 1.2 Both
Blood products given 582 2.41 35.7 (12.8-64.9) 98.4 (97.0-99.3) 2.4 0.67 (0.63-0.71) 1.0 Both
Receives injection or IVg
medication for induction
or augmentation of labor
476 76.1 59.1 (53.9-64.2) 79.8 (71.3-86.8) 49.8 0.69 (0.65-0.74) 0.65 AUC
Augments labor with uterotonic 472 75.2 49.6 (44.3-54.9) 81.2 (72.9-87.8) 42.0 0.65 (0.61-0.70) 0.56 AUC
Membranes ruptured (labor
induction or augmentation)
356 57.0 38.4 (31.7-45.5) 88.2 (82.0-92.9) 27.0 0.63 (0.58-0.68) 0.47 AUC
Breastfeeding initiated within
first hour of birthi
449 34.7 81.4 (74.4-87.2) 44.1 (38.3-49.9) 64.8 0.63 (0.58-0.67) 1.9 AUC
First post-delivery exam,
provider checks for involution
556 81.7 84.6 (80.9-87.8) 21.6 (14.0-30.8) 83.5 0.53 (0.49-0.57) 1.0 IF
Palpates uterus after delivery
of placenta
580 82.4 79.5 (78.4-85.5) 19.6 (9.7-25.4) 79.7 0.50 (0.45-0.54) 0.97 IF
Uterotonic received 1-3 min
after birth
580 64.0 61.5 (56.3-66.4) 40.7 (33.9-47.7) 60.7 0.51 (0.47-0.55) 0.95 IF
3 AMTSLh elements: prophylactic
uterotonic + controlled cord
traction + uterine massage
following delivery of placenta
549 81.2 75.7 (71.5-79.6) 24.0 (16.0-33.6) 75.7 0.50 (0.46-0.54) 0.93 IF
HIV status checked 569 69.8 54.9 (49.9-59.9) 47.7 (40.0-55.4) 54.1 0.51 (0.47-0.55) 0.78 IF
Induces labor with uterotonic 559 11.6 27.7 (17.3-40.2) 89.1 (86.0-91.7) 12.9 0.58 (0.54-0.62) 1.1 IF
Woman received pain relief
medication
581 79.4 89.4 (86.2-92.0) 20.0 (13.3-28.3) 87.4 0.55 (0.51-0.59) 1.1 IF
First post-delivery exam,
provider ask/checks for bleeding
590 80.5 87.4 (84.0-90.2) 12.2 (6.8-19.6) 87.5 0.50 (0.46-0.54) 1.1 IF
First post-delivery exam,
provider examines perineum
586 75.1 90.2 (87.1-92.8) 10.3 (5.9-16.4) 90.1 0.50 (0.46-0.54) 1.2 IF
First post-delivery exam,
provider takes temperature
586 66.9 94.4 (91.6-96.4) 8.8 (5.2-13.7) 93.4 0.52 (0.47-0.56) 1.4
Encourages/assists woman
to ambulate during labor
580 22.2 7.8 (3.8-13.8) 91.6 (88.6-94.0) 8.3 0.50 (0.46-0.54) 0.37
Woman asked for pain relief
medication at some time
575 44.7 32.7 (27.0-38.8) 78.9 (74.0-83.3) 26.3 0.56 (0.52-0.60) 0.59
Something other than
breastmilk given to baby
within first hour of birthi
438 21.7 71.6 (61.4-80.4) 46.1 (40.7-51.5) 57.8 0.59 (0.54-0.64) 2.7
Uterotonic received 1-3 min
after delivery of placenta
576 20.0 95.7 (90.1-98.6) 6.3 (4.3-8.9) 94.1 0.51 (0.47-0.55) 4.7
Baby given to mother
immediately after birthi
580 10.3 63.3 (49.9-75.4) 40.6 (36.3-44.9) 59.8 0.52 (0.48-0.56) 5.8
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elements (e.g., reporting “Hospital público”, “Hospital
federal”, or “Hospital de asistencia pública”); the open-
ended probe elicits additional correct information not
captured initially in the categorical response.
Content of care
We validated 21 indicators related to interventions re-
ceived throughout labor and the immediate postnatal
period. Indicators of content of care with the highest indi-
vidual-level accuracy were episiotomy (AUC: 0.80, 95
% CI: 0.77–0.84), followed by receiving an injection for
the induction or augmentation of labor (AUC: 0.69, 95 %
CI: 0.65–0.74), urine sample screen upon hospital admis-
sion, (AUC: 0.67, 95 % CI: 0.67–0.71) and receipt of blood
products (AUC: 0.67, 95 % CI: 0.63 – 0.71). Indicators
related to the third stage of labor, including receiving an
injection or medication following delivery (i.e., uterotonic
for the prevention of postpartum hemorrhage) and imme-
diate postnatal care for the mother had moderate or low
overall individual level validity.
Population-level accuracy for 13 content of care
indicators were within 25 % of the true prevalence (0.75
< IF < 1.25). Overestimation was nearly double or greater
the observed prevalence for four indicators: the infant
was placed with the mother immediately after birth
(5.8), receipt of an injection or medication following
delivery of the placenta (i.e., uterotonic for the pre-
vention of postpartum hemorrhage) (4.7), something
other than breastmilk was given to the infant within
the first hour of birth (2.7), and breastfeeding initi-
ated in the first hour of birth (1.9).
Uterotonic for prevention of postpartum hemorrhage
A critical component of maternal health care is receipt of a
uterotonic for the prevention of hemorrhage, a leading
cause of maternal death in Mexico and globally [18, 19].
Women were asked whether, “Immediately after the deliv-
ery of your baby, did anyone given you” (1) “an injection in
your thigh or buttocks”, (2) “medication intravenously
(through a tube in your arm”, or (3) “tablets to swallow or
hold in your mouth”, or (4) “tablets placed in your rectum”.
As the standard of care in the study facility was administra-
tion of the uterotonic via intravenous injection (100 % of
cases observed), there was insufficient sample size to assess
each of these indicators independently. Given this, we
compared a combined indicator comprised of women who
Table 3 Validation results for maternal and newborn intrapartum and immediate postnatal care indicators † (Continued)
Maternal Complications
Severe bleeding (hemorrhage) 593 8.1 50.0 (35.2-64.8) 95.2 (93.1-96.9) 8.4 0.73 (0.69-0.76) 1.0 Both
High blood pressure/convulsions
(eclampsia)
594 2.4 57.1 (28.9-82.3) 79.5 (76.0-82.7) 21.4 0.68 (0.64-0.72) 9.1 AUC
Complication (yes to any) 595 13.6 60.5 (50.3-72.3) 65.4 (61.3-69.7) 38.2 0.64 (0.60-0.68) 2.8 AUC
None 595 86.4 65.6 (61.3-69.7) 61.7 (50.3-72.3) 61.8 0.64 (0.60-0.68) 0.72 AUC
†Validation analysis based on matched data, excluding ‘Don’t Know’ and missing responses. Sensitivity and specificity analysis was not performed for indicators
that had fewer than 5 counts per cell of constructed two-by-two tables
aTrue prevalence refers to prevalence of intervention or event as measured by direct observation by a trained third party in the study hospital facility; bTrue
positive rate; cTrue negative rate; dEstimated prevalence that would be obtained through women’s self-report in a household survey (Pr), calculated using the
following equation where P = true prevalence, SE = sensitivity, SP = specificity, Pr = P*(SE + SP-1) + (1-SP); eIF = Pr/P, or ratio of survey-based prevalence to the true
prevalence; fAUC > 0.60 and 0.75 < IF < 1.25; gIV refers to intravenous medication; hRefers to active management of the third stage of labor; iQuestions asked of
mothers whose infants were breathing at birth
*Note: For full description of study indicators, please see Additional file 5: Table S1
Table 4 Cross-tabulation of women’s response and observer report of the main provider during delivery
Self- report (Number) Observer report (Number)
Doctor /Ob-gyn Medical resident Medical intern Nurse Student nurse Self-report total
Doctor /Ob-gyn 14 487 40 1 0 542
Medical resident 0 17 0 0 0 17
Medical intern 0 11 2 0 0 13
Nurse 0 11 0 1 0 12
Student nurse 0 0 0 0 0 0
Don’t Know 0 9 2 0 0 11
Observer Total 14 535 44 2 0 595
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reported “Yes” to any method of uterotonic administration
within the first few minutes of birth against the observer
report of whether the woman received a uterotonic within
three minutes of birth. The observed prevalence was 61 %
and the reported prevalence was 64 %. The indicator did
not meet the AUC (0.51, 95 % CI: 047–0.55) but did meet
the IF criterion (0.95).
Women were asked the same set of questions about
the first few minutes after the delivery of the
placenta. A combined indicator constructed from
women’s reports of whether she received a uterotonic
via any method met neither criteria (AUC 0.51, 95 %
CI: 0.47–0.55; IF 4.7). The specificity of this indicator
(6 %, 95 % CI: 4–9 %) was low.
We attempted to validate an alternative indicator
that used the name of the uterotonic drug and its
purpose. Women were asked whether, “Immediately
after the birth of your baby, did anyone give you a
medication or injection called oxytocin to help your
womb contract/become firm?” In the study facility,
oxytocin was the standard uterotonic (administered in
97 % of cases). However, of women who reported
“Yes” to any of the methods of uterotonic administra-
tion, 62 % responded either “Don’t Know” or “No” to
the oxytocin question. While there was insufficient
sample size to robustly analyze this indicator, descrip-
tive results show that, among women who were
observed to receive oxytocin and who gave a valid
response to the question, 50 % accurately reported
receiving the medication by its name.
Maternal complications
Women were asked whether they had experienced a list
of several obstetric complication symptoms (e.g., exces-
sive bleeding, prolonged labor, high blood pressure, con-
vulsions). There was sufficient sample size to assess the
validity of four indicators based on these questions. One
indicator- excessive bleeding (hemorrhage), met both ac-
ceptability criteria (IF 1.0, AUC 0.73, 95 % CI: 0.69–
0.76). This indicator high specificity (95.2 %, 95 % CI:
93.1–96.9) but moderate sensitivity (50.0 %, 95 % CI:
35.2–64.8 %); nearly half of women who experienced ex-
cessive bleeding would not be captured in a survey ques-
tion. The other three indicators met the individual
criteria only and were overreported by women at the
population level. For example, experiencing high blood
pressure and convulsions (eclampsia) was overestimated
by over 9 times at the population level (IF 9.1), although
the low prevalence means that even slightly less than
perfect reporting can lead to large overestimation.
Discussion
Indicators that measure contact with the health system
in addition to the quality of received care are critical for
measuring progress in improving maternal and newborn
health. This is the first study to empirically validate indi-
cators related to the contact, quality and outcomes of
maternal and immediate newborn postnatal care in
Mexico. A strength of this study is the use of direct
observation as the reference standard.
Few indicators assessed in the present study met both
study validity criteria. This occurred in part because
many interventions were routine practice and there was
insufficient variation in the observed prevalence for
robust analysis. However, an additional 9 indicators met
the individual-level criteria and 18 met the population-
level criteria. Indicators that did not meet both criteria
are not necessarily invalid for all measurement purposes,
but should be used in accordance with the rationale for
their use. For example, indicators that do not meet cri-
teria for the AUC but do meet the IF criterion may be
suitable to measure intervention coverage at the
population-level as false positive and negative reporting
balance each other at the aggregate level.
Our findings also highlight the challenges of measur-
ing low prevalence indicators accurately. Given that the
calculation of the IF depends upon the indicator’s
observed prevalence, even a small number of false posi-
tive responses can result in overestimation as measured
by the IF. The implications of varying ‘true’ prevalence
rates on the estimated prevalence that would be
obtained from women in a household survey is illus-
trated in a previous article [13]. Additional validation
work is needed to identify appropriate strategies for
measuring low prevalence indicators, such as maternal
complications and non-indicated practices.
The consistency of our results with prior findings is
mixed. For example, the moderate sensitivity and high
specificity for reported symptoms of hemorrhage (exces-
sive bleeding) corresponds with levels found among
women delivering in Indonesia, Benin and the Philippines
[20–22]. However, these results differ from women’s
reporting in Taiwan and Ghana [23]. We also found high
sensitivity and low specificity for an indicator of whether
or not the woman received a uterotonic within the first
few minutes of birth; which differs from the low sensitivity
and moderate specificity documented in a study con-
ducted in Mozambique [12]. Taken together, these find-
ings suggest that women’s understanding and recall of
interventions received and obstetric complications experi-
enced may vary by clinical and cultural context, and rein-
forces the importance of validating women’s reporting in
different settings.
No contact with care indicators that we were able to
assess (i.e., indicators of skilled birth attendance) met
both validation criteria. However, a combined indicator
of whether the primary birth attendant during delivery
was a doctor/ob-gyn or medical resident did meet the
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criteria for valid estimation at the population level.
Given that broad categorizations of provider types are
likely to be more programmatically meaningful than the
ability of women to delineate between finer categories of
qualified health professionals (e.g., doctors versus med-
ical residents), a composite indicator is likely to have
utility for assessing population-level coverage. It is
important to recognize, however, that skilled attendance
is not synonymous with receiving appropriate care. Even
a competent provider may not be able to provide high
quality care if necessary supplies and other aspects of
the enabling environment are inadequate [24, 25]. When
possible, self-reported data should be triangulated with
other data sources, such as stock-outs of essential medi-
cines [26, 27].
Given that “skilled attendance” cannot be used reliably
as a proxy for quality of care, indicators that measure
the content of care administered by providers should
also be assessed. Across content of care indicators
assessed in this study, however, we observed a tendency
for women to overreport some standard prevention
practices, particularly related to the initial client assess-
ment and immediate postnatal care for the mother and
newborn. The high sensitivity and low specificity of
many of these indicators suggests that in the few in-
stances when an intervention was not administered,
women tended to falsely report that it had occurred.
One potential explanation for this pattern is facility
bias, or the assumption by women that they received
quality care due to the fact that they delivered in a
health facility [10, 13]. For example, more careful prob-
ing of some indicators of care, such as whether an injec-
tion or IV medication was received before birth (i.e.,
uterotonic for induction or augmentation of labor), or
following delivery (i.e., uterotonic for prevention of post-
partum hemorrhage) suggests that women did not know
the specific indication for the care received, just that an
intervention occurred. Validation results for the utero-
tonic indicators may reflect more general knowledge
women had about having an IV line set, which was
standard hospital practice for all women entering the
labor and delivery ward, rather than knowledge of which
medication was given or why. For example, neither an
indicator of whether “an injection or IV medication was
received to speed up labor” (i.e., uterotonic induction of
labor) or whether “an injection or IV medication was re-
ceived to strengthen labor” (i.e., uterotonic for augmen-
tation of labor) met both validation criteria, while a
general indicator of receiving an injection or IV medica-
tion at some time before the birth of the baby did. Simi-
larly, most women correctly reported receipt of a
uterotonic within the first few minutes after delivery of
the baby, but also falsely reported the receipt of a utero-
tonic within the first few minutes after the delivery of
the placenta, suggesting women may be able to report
that some intervention occurred, but not be able to re-
port accurately on aspects of its timing or purpose.
In light of the tendency for overreporting in a facility
setting, high specificity for an indicator of receipt of a
uterotonic may be favored at the cost of sensitivity. The
near universal administration of oxytocin limited our
ability to determine if an alternate uterotonic indicator
that used the name of the drug and its purpose would
achieve higher specificity as opposed to an indicator that
asks women about the route of drug administration. Our
descriptive results, however, did show that use of an
indicator that uses the drug name captured substantially
fewer true cases and fewer women were able to answer
the question at all. This suggests that asking about
receipt of a uterotonic using the drug name and reason
for its use may not be a better alternative to asking
women about whether they received an injection or
some other method of drug administration.
An alternate explanation for positive reporting bias by
women is that mothers misunderstood or conceptualized
the meaning of questions differently than the observer
definitions. For example, indicators with the highest
“Don’t Know” responses generally included (1) technical
terms, such as medication or disease names, related to
the (2) timing of interventions received (including the
sequence of newborn thermal care), or (3) the immedi-
ate postnatal period. Anecdotal evidence from study
interviewers shows that additional explanation was
needed to describe the difference between HIV vs. HPV,
intravenous vs. intramuscular drug administration, and
to define epidurals. Questions to which a substantial
percentage of women responded “Don’t Know” (e.g.
20 % or more) are unlikely to yield valid information via
self-reports and are not recommended for inclusion in
population-based surveys.
Our findings highlight the importance of a two-part
question with an open-ended component to improving
reporting for complex indicators, such as the type of in-
stitution where the woman delivered. The fact that add-
itional women could identify key facility attributes in an
open-ended format suggests that providing the oppor-
tunity for women to name the specific facility, as is done
in both the DHS and MICS surveys, is advantageous for
capturing information on institutional deliveries.
While the study provides useful insight regarding the
validity of contact and content of care indicators, there
were some limitations. Due to budget limitations, the
validation exercise took place in one type of facility only.
Our study results are therefore reflective of women who
delivered in a large public hospital. For example, although
institutional delivery is near universal in Mexico (94 %), it
is higher among women who reside in urban relative than
rural areas (96 % and 88 %, respectively) and our results
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may be more reflective of this type of population [28]. The
minimal variation in standard hospital procedures limited
our ability to assess all indicators, which may have other-
wise been proven valid. Additionally, in the study setting
relatively few women experienced complications such as
eclampsia, a leading cause of maternal death in Latin
America and the Caribbean. It is possible that with a
greater sample size, different combinations of questions
regarding the symptoms of eclampsia could be validated
to identify question wording with the highest accuracy.
Another limitation it that, due to hospital policy, it
was not possible to include women who became indi-
cated for a cesarean section delivery in the study. Future
research should extend this work to a broader range of
types of health facilities, including health centers and
clinics, and may have the potential to validate the
reporting accuracy of women who underwent a cesarean
delivery. Validation research in other types of facilities
may also reduce the potential for positive facility bias in
reporting. Finally, exit interviews with women occurred
shortly following delivery, prior to hospital discharge.
The short recall time may cause women’s self-reports to
be more accurate than in population level surveys such
as the DHS and MICS when women are typically inter-
viewed about a birth that took place one to three years
prior. As part of an overall program of work on indicator
validation, a separate follow-up study is underway to re-
interview women approximately one year following
delivery in Kenya.
Conclusion
As attention in maternal health shifts to a new emphasis
on ending preventable maternal mortality (EPMM) and
addressing inequities, the tracking of progress will re-
main important [29]. A key aspect of these future efforts
will require the valid measurement of not only contact
with maternal and newborn health services but also
coverage of key interventions that reflect the quality of
services received. Until recently, however, little attention
has been paid to improving the measurement of inter-
vention coverage and quality at the population level.
This information is needed to set programmatic prior-
ities and to allocate resources effectively. Given the ef-
fect that this information can have on improvements in
the lives of women and newborns, priority should be
given to work that ensures that indicators of progress
are selected, measured, and interpreted accurately.
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